METFORMIN USE AND RISK OF PROSTATE CANCER: RESULTS FROM THE REDUCE STUDY

被引：0
|
作者：
Feng, Tom
Sun, Xizi
Howard, Lauren
Vidal, Adriana
Moreira, Daniel
Castro-Santamaria, Ramiro
Andriole, Gerald
Freedland, Stephen
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.1936
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP04-01
引用
收藏
页码：E27 / E27
页数：1
相关论文
共 50 条
  • [21] Statin Use and Risk of Prostate Cancer: Results From the Southern Community Cohort Study
    Kantor, Elizabeth D.
    Lipworth, Loren
    Fowke, Jay H.
    Giovannucci, Edward L.
    Mucci, Lorelei A.
    Signorello, Lisa B.
    PROSTATE, 2015, 75 (13): : 1384 - 1393
  • [22] Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study
    Jonathan L. Wright
    Janet L. Stanford
    Cancer Causes & Control, 2009, 20
  • [23] Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study
    Sourbeer, Katharine N.
    Howard, Lauren E.
    Andriole, Gerald L.
    Moreira, Daniel M.
    Castro-Santamaria, Ramiro
    Freedland, Stephen J.
    Vidal, Adriana C.
    BJU INTERNATIONAL, 2015, 115 (05) : 736 - 743
  • [24] Smoking and Risk of Low- and High-Grade Prostate Cancer: Results from the REDUCE Study
    Ho, Tammy
    Howard, Lauren E.
    Vidal, Adriana C.
    Gerber, Leah
    Moreira, Daniel
    McKeever, Madeleine
    Andriole, Gerald
    Castro-Santamaria, Ramiro
    Freedland, Stephen J.
    CLINICAL CANCER RESEARCH, 2014, 20 (20) : 5331 - 5338
  • [25] Prostate Cancer Risk in Men with Baseline History of Coronary Artery Disease: Results from the REDUCE Study
    Thomas, Jean-Alfred, II
    Gerber, Leah
    Banez, Lionel L.
    Moreira, Daniel M.
    Rittmaster, Roger S.
    Andriole, Gerald L.
    Freedland, Stephen J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (04) : 576 - 581
  • [26] Efficacy and Safety of Dutasteride on Prostate Cancer Risk Reduction in Asian Men: The Results from the REDUCE Study
    Akaza, Hideyuki
    Kanetake, Hiroshi
    Tsukamoto, Taiji
    Miyanaga, Naoto
    Sakai, Hideki
    Masumori, Naoya
    Nakatsu, Hiroomi
    Sagiyama, Kazuyuki
    Sakamoto, Sadaaki
    Endo, Yukihiro
    Yamanouchi, Takayoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (03) : 417 - 423
  • [27] Duration of Metformin Use and Risk of Prostate Cancer in Men with Diabetes
    Habel, Laurel A.
    Van Den Eeden, Stephen K.
    Sakoda, Lori C.
    Achacoso, Ninah S.
    Quesenberry, Charles P.
    Peng, Tiffany
    Ehrlich, Samantha F.
    Ferrara, Assiamira
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 170 - 170
  • [28] Risk analysis of metformin use in prostate cancer: a national population-based study
    Lai, Shih-Wei
    Hwang, Bing-Fang
    Liu, Chiu-Shong
    Liao, Kuan-Fu
    AGING MALE, 2024, 27 (01):
  • [29] Risk analysis of metformin use in prostate cancer: a national population-based study
    Jo, Jung Ki
    Song, Hae Kyung
    Heo, YongKi
    Kim, Mi Jeong
    Kim, Yun Jin
    AGING MALE, 2023, 26 (01):
  • [30] BASELINE PROSTATE INFLAMMATION IS ASSOCIATED WITH REDUCED RISK OF PROSTATE CANCER IN MEN UNDERGOING REPEAT PROSTATE BIOPSY: RESULTS FROM THE REDUCE STUDY
    Moreira, Daniel
    Nickel, J. Curtis
    Gerber, Leah
    Muller, Roberto
    Andriole, Gerald
    Castro-Santamaria, Ramiro
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2013, 189 (04): : E272 - E272
12345